𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells

✍ Scribed by J. M. Gimble; C. Morgan; K. Kelly; X. Wu; V. Dandapani; C.-S. Wang; V. Rosen


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
870 KB
Volume
58
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


The bone morphogenetic proteins were originally identified based on their ability to induce ectopic bone formation in vivo and have since been identified as members of the transforming growth factor-@ gene superfamily. It has been well established that the bone morphogenetic cytokines enhance osteogenic activity in bone marrow stromal cells in vitro. Recent reports have described how bone morphogenetic proteins inhibited myogenic differentiation of bone marrow stromal cells in vitro. In vivo, bone marrow stromal cells differentiate along the related adipogenic pathway with advancing age. The current work reports the inhibitory effects of the bone morphorphogenetic proteins on adipogenesis in a multipotent murine bone marrow stromal cell line, BMS2. When exposed to bone morphogenetic protein-2, the pre-adipocyte BMS2 cells exhibited the expected induction of the osteogenic-related enzyme, alkaline phosphatase. Following induction of the BMS2 cells with adipogenic agonists, adipocyte differentiation was assessed by morphologic, enzymatic, and mRNA markers. Flow cytometric analysis combined with staining by the lipophilic fluorescent dye, Nile red, was used to quantitate the extent of lipid accumulation within the BMS2 cells. By this morphologic criteria, the bone morphogenetic proteins inhibited adipogenesis at concentrations of 50 to 500 ng/ml. This correlated with decreased levels of adipocyte specific enzymes and mRNAs. The BMS2 pre-adipocytes constitutively expressed mRNA encoding bone morphogenetic protein-4 and this was inhibited by adipogenic agonists. Together, these findings demonstrate that bone morphogenetic proteins act as adipogenic antagonists. This supports the hypothesis that adipogenesis and osteogenesis in the bone marrow microenvironment are reciprocally regulated.


πŸ“œ SIMILAR VOLUMES


Bone morphogenetic protein-2 decorated s
✍ Karageorgiou, Vassilis ;Meinel, Lorenz ;Hofmann, Sandra ;Malhotra, Ajay ;Volloch πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 1 views

## Abstract Bone morphogenetic protein (BMP)‐2 has a critical role in bone formation and regeneration. Therefore, the ability to immobilize this molecule in certain matrices may be crucial in bone tissue engineering. Using carbodiimide chemistry, BMP‐2 was directly immobilized on silk fibroin films

Regulation of bone matrix protein expres
✍ Fernando Lecanda; Louis V. Avioli; Su-Li Cheng πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 592 KB

We have examined the effects of BMP-2 on the expression of bone matrix proteins in both human bone marrow stromal cells (HBMSC) and human osteoblasts (HOB) and their proliferation and mineralization. Both HBMSC and HOB express BMP-2/-4 type I and type II receptors. Treatment of these two cell types

Bone morphogenetic protein-2 and transfo
✍ O. FromiguΓ©; P.J. Marie; A. Lomri πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 458 KB πŸ‘ 1 views

Osteoprogenitor cells in the human bone marrow stroma can be induced to differentiate into osteoblasts under stimulation with hormonal and local factors. We previously showed that human bone marrow stromal (HBMS) cells respond to dexamethasone and vitamin D by expressing several osteoblastic markers

Polymethylmethacrylate particles inhibit
✍ Richard Chiu; Ting Ma; R. Lane Smith; Stuart B. Goodman πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 1 views

## Abstract Aseptic implant loosening of total joint replacements often results from particle‐mediated bone loss, which may be a combined effect of osteolysis and suppressed bone formation. Bone regeneration in the prosthetic bed depends on the activity of osteoblasts and their differentiation from